Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$2.44
-$0.10 (-3.94%)
At close: Oct 30, 2026, 4:00 PM ET
$2.44
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 4:01 AM ET
-3.94%
(1D)No price chart data available for 1D timeframe.
Rating
36.8
+0.6 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #609/1028 (Top 59%)
Key Statistics
Market Data
Market Cap $267.85M
1D Range
2.37 2.57
52W Range
2.18 5.30
Valuation (TTM)
PE -14.35
PB 0.73
EV/EBITDA 1.12
Valuation (NTM)
Forward PE N/A
Forward PEG 0.16
Price Target $5.32
Cash Flow
FCF Yield -63.6%
SBC Adj. FCF Yield -75.5%
SBC Impact -18.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 71.8% |
27.2%
FCF 3Y | 5Y 10.3% |
-1.7%
Returns
ROA -4.1%
ROE -5.8%
ROIC -48.5%
Financial Health
Net Cash
$283.75M
Current Ratio 9.24
Interest Coverage -40.53
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The comp...
Sector Healthcare
Industry Biotechnology
Employees 202
IPO Date Feb 18, 2015
Website rocketpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
8
Consensus
Buy
Price Target
$4.00
Upside
+63.93%
Buy (5)
Hold (2)
Sell (1)
Add to Watchlist
Select watchlists to add or remove RCKT